feed,title,long_url,short_url
Benzinga,"Regeneron Requests Emergency Use Authorization, Analysts See Coronavirus Antibodies As Earnings Driver In 2021",https://www.benzinga.com/analyst-ratings/analyst-color/20/10/17839297/regeneron-requests-emergency-use-authorization-analysts-see-coronavirus-antibodies-,https://j.mp/34w5p9a
